Hip Hinge Instruction for Lower Back Pain
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Founder Exercise for lower back pain?
Is the hip hinge exercise safe for humans?
How is the Founder Exercise treatment different from other treatments for lower back pain?
The Founder Exercise treatment is unique because it focuses on teaching proper hip hinge movements, which can help reduce strain on the lower back by improving hip flexibility and strength. This approach is different from other treatments that may not specifically target the hip's role in managing lower back pain.110111213
What is the purpose of this trial?
To evaluate if the Founder exercise will significantly change participants kinematics when performing hip hinge movement. Secondary purpose is to evaluate if completing the Founder Exercise intervention will improve confidence in performing a hip hinge.
Eligibility Criteria
This trial is for individuals experiencing lower back pain or arthritis who are interested in improving their hip hinge movement, which is important for activities like lifting. Specific eligibility criteria have not been provided, so it's best to contact the study organizers for more details.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-intervention assessment
Baseline data collection including demographic information, confidence scale, and placement of reflective markers
Intervention
Participants receive 8 minutes of instruction on the Founder Exercise and perform 10 practice repetitions
Post-intervention assessment
Reassessment of hip hinge movement and grip strength, completion of confidence scale
Follow-up
Participants are monitored for any adverse effects and can request their individual results
Treatment Details
Interventions
- Founder Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Central Florida
Lead Sponsor